Paradoxically, in sorafenib-resistant hepatocellular carcinoma (HCC) models, FASN orchestrates nuclear accumulation of HIF1α to drive SLC7A11 transactivation, thereby conferring ferroptosis resistance [30]. Here, SLC7A11 is linked to hepatocellular carcinoma.